Karriere bei Cptx

CAR T therapy has saved roughly 50,000 lives but today's bespoke cell manufacturing does not scale. Addressing scalability and accessibility while preserving CAR T’s transformative biology could improve millions of lives. CPTx addresses this need by programming CAR T cells directly inside the patient, delivering engineered DNA vectors to T cells via lipid nanoparticles. Unlike mRNA, DNA offers durable expression, critical for treating cancer. Unlike viral vectors, CPTx's DNA system supports redosable and tunable, multi-gene payloads. CPTx has developed purpose-built technology across every layer of the platform: proprietary immune-quiet DNA vectors, custom LNP formulations, and targeting strategies that direct the payload to T cells.

Arbeiten bei Cptx